Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.34
Delayed Data
As of Dec 14
 0.00 / 0.00%
Today’s Change
1.93
Today|||52-Week Range
4.70
-26.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-3.7M-2.8M-4.3M-2.6M
 
 
 
 
 
Depreciation313.9K52.3K7.0K3.0K
 
 
 
 
 
Total Other Cash Flow1.4M500.8K2.5M1.0M
 
 
 
 
 
Funds From Operations-2.0M-2.3M-1.8M-1.5M
 
 
 
 
 
Funds From/For Other Operating Expenses482.3K163.7K16.0K220.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-2.5M-2.4M-1.9M-1.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-10.0K0.00
 
 
Decrease In Investments3.4M1.5M21.0K0.00
 
 
 
 
Capital Expenditures-84.2K-7.9K-2.0K-2.0K
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-55.0K0.00
 
 
Net Cash Flow Investing3.3M1.5M-110.0K-66.2K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale317.9K304.6K3.6M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.0020.0K0.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing317.9K304.6K3.6M0.00
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash37.1K-13.8K-2.0K--
 
 
 
 
 
Net Change In Cash1.2M-652.7K1.6M-1.8M